Sign in

Research summary ·

Melatonin Supplementation in the Management of Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This study pooled results from earlier trials of melatonin for IBS. IBS is a gut problem with belly pain and changed bowel habits. The trials included 391 adults with IBS. Each trial compared melatonin with a dummy pill, called a placebo. Neither the people nor the staff knew who got which pill. Melatonin was taken by mouth or under the tongue. The team looked for studies up to April 2026.

What they found

Fewer people on melatonin had moderate or severe IBS symptoms. Pain came less often with melatonin than with the placebo. People on melatonin also had better results for how often they had bowel movements. Quality of life and sleep did not differ clearly between the groups. Belly swelling and pain strength leaned toward melatonin, but not clearly. Side effects were mild and did not happen often.

What it means for patients

The authors say melatonin may ease IBS symptoms overall. It may also help with pain and bowel habits. In the short term, it seemed safe enough. It did not clearly help quality of life or sleep.

Why it is not certain yet

The authors say larger, high-quality trials are still needed. These trials should check if the benefit lasts in the long term. Safety is only known for the short term. Not all trials could be pooled together in the numbers. A review can only be as good as the studies in it.

Source

Melatonin Supplementation in the Management of Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.

PubMed · PMID 42770627

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Irritable bowel syndrome publications